Literature DB >> 27800056

One is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason grading.

John R Srigley1, Brett Delahunt2, Lars Egevad3, Hemamali Samaratunga4, John Yaxley5, Andrew J Evans6.   

Abstract

Entities:  

Year:  2016        PMID： 27800056      PMCID： PMC5085914          DOI： 10.5489/cuaj.4146

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  32 in total

1.  The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.

Authors:  Burkhard Helpap; Lars Egevad
Journal:  Virchows Arch       Date:  2006-11-08       Impact factor: 4.064

2.  A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

Authors:  Zachary S Zumsteg; Daniel E Spratt; Isaac Pei; Zhigang Zhang; Yoshiya Yamada; Marisa Kollmeier; Michael J Zelefsky
Journal:  Eur Urol       Date:  2013-03-23       Impact factor: 20.096

3.  Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?

Authors:  Danil V Makarov; Harriete Sanderson; Alan W Partin; Jonathan I Epstein
Journal:  J Urol       Date:  2002-06       Impact factor: 7.450

4.  Clinical characteristics in black and white men with prostate cancer in an equal access medical center.

Authors:  S J Freedland; M E Sutter; J Naitoh; F Dorey; G S Csathy; W J Aronson
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

5.  Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

Authors:  Brandon A Mahal; Vinayak Muralidhar; Yu-Wei Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Christopher J Sweeney; James B Yu; Felix Y Feng; Quoc-Dien Trinh; Paul L Nguyen
Journal:  BJU Int       Date:  2015-08-22       Impact factor: 5.588

Review 6.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

7.  Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort.

Authors:  Jonathan L Wright; Claudia A Salinas; Daniel W Lin; Suzanne Kolb; Joseph Koopmeiners; Ziding Feng; Janet L Stanford
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

8.  Prognostic factors in carcinoma of the prostate--analysis of RTOG study 75-06.

Authors:  M V Pilepich; J M Krall; W T Sause; R J Johnson; H H Russ; G E Hanks; C A Perez; M Zinninger; K L Martz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

9.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup.

Authors:  J I Epstein; M Carmichael; A W Partin; P C Walsh
Journal:  J Urol       Date:  1993-06       Impact factor: 7.450

10.  Overall and worst gleason scores are equally good predictors of prostate cancer progression.

Authors:  Teemu T Tolonen; Paula M Kujala; Teuvo L J Tammela; Vilppu J Tuominen; Jorma J Isola; Tapio Visakorpi
Journal:  BMC Urol       Date:  2011-10-06       Impact factor: 2.264
View more
  4 in total

1.  Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings.

Authors:  K R Beckmann; A D Vincent; M E O'Callaghan; P Cohen; S Chang; M Borg; S M Evans; D M Roder; K L Moretti
Journal:  BMC Cancer       Date:  2017-08-10       Impact factor: 4.430

2.  The current status of renal cell carcinoma and prostate carcinoma grading.

Authors:  Brett Delahunt; Lars Egevad; John Yaxley; Hemamali Samaratunga
Journal:  Int Braz J Urol       Date:  2018 Nov-Dec       Impact factor: 1.541

3.  TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss.

Authors:  Karolina Pietrzak; Rostyslav Kuzyakiv; Ronald Simon; Marco Bolis; Dominik Bär; Rossana Aprigliano; Jean-Philippe Theurillat; Guido Sauter; Raffaella Santoro
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-05       Impact factor: 11.205

4.  Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications.

Authors:  William John Yaxley; François-Xavier Nouhaud; Sheliyan Raveenthiran; Anthony Franklin; Peter Donato; Geoff Coughlin; Boon Kua; Troy Gianduzzo; David Wong; Robert Parkinson; Nicholas Brown; Hemamali Samaratunga; Brett Delahunt; Lars Egevad; Matthew Roberts; John William Yaxley
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-30       Impact factor: 5.554
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.